Clinical Trials Logo

Tourette Syndrome clinical trials

View clinical trials related to Tourette Syndrome.

Filter by:

NCT ID: NCT05628805 Recruiting - Tourette Syndrome Clinical Trials

Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome

Start date: November 1, 2022
Phase: Early Phase 1
Study type: Interventional

Decades of Tourette Syndrome (TS) neuroimaging research has revealed abnormal cortical and subcortical motor system network, hypothesized to result from maladaptive plasticity. Repetitive transcranial magnetic stimulation ([r]TMS) is a promising technology that utilizes the concept of neuroplasticity to modulate brain circuits. TMS modulation has the distinct advantage in terms of its non-invasive nature. Furthermore, unique stimulation paradigms such as intermittent theta-burst repetitive TMS (iTBS) allows for short stimulation time (<3 min). Using a sham-controlled protocol, the investigators propose modulating pre-SMA output using iTBS, based on our prior data of abnormal pre-SMA-mediated motor system regulation. hypothesize pre-SMA modulation results in increased pre-SMA-mediated motor inhibition. Enhancing these inhibitory measures with pre-SMA-iTBS provides the basis for improving inhibitory function in TS patients, leading to our long-term goal of neuro-stimulation to achieve clinical tic reduction.

NCT ID: NCT05615220 Recruiting - Tourette Disorder Clinical Trials

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

D1AMOND
Start date: January 31, 2023
Phase: Phase 3
Study type: Interventional

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by double-blind, placebo-controlled, randomized withdrawal period.

NCT ID: NCT05566496 Recruiting - Clinical trials for Tourette Syndrome in Children

The Findings of Magnetic Resonance Imaging in Subtypes of Tics-related Disorders

Start date: October 20, 2022
Phase:
Study type: Observational

The findings of resting-state functional magnetic resonance imaging and diffusion spectrum imaging in subtypes of tics-related disorders

NCT ID: NCT05566236 Recruiting - Depression Clinical Trials

Board Game Project for Adolescents With Tourette Syndrome

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate the effectiveness of using an evidence-based board game scheme to improve the tics and interpersonal interactions of adolescents with Tourette syndrome.

NCT ID: NCT05558566 Recruiting - Clinical trials for Tourette Syndrome in Adolescence

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).

NCT ID: NCT05547854 Recruiting - Tourette Syndrome Clinical Trials

Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program

CBIT-Trainer
Start date: June 27, 2023
Phase: N/A
Study type: Interventional

Tic disorders are a class of childhood-onset neuropsychiatric disorders that occur in 1-3% of the population. Studies have shown that a non-drug treatment known as Comprehensive Behavioral Intervention for Tics (CBIT) is more effective than supportive therapy for reducing tics in children and adults. Although CBIT is now recommended as a first-line intervention for tic disorders, many patients do not have access to CBIT, in part due to a lack of trained therapists. Currently, the only option available for training therapists in CBIT is an intensive, two day, in-person behavior therapy training institute (BTTI). This study will compare the traditional in-person training approach to a recently developed online, self-paced CBIT therapist training program called CBIT-Trainer with regard to (1) therapists' ability to accurately administer CBIT and (2) change in the severity of patients' tic symptoms after being treated by a CBIT-trained therapist.

NCT ID: NCT05499741 Recruiting - Insomnia Clinical Trials

Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder

Start date: April 27, 2023
Phase: N/A
Study type: Interventional

The primary aim of the present research project is to investigate the preliminary effects of four weeks of forehead temperature-regulating therapy on insomnia in adults with Tourette's disorder and co-occurring insomnia disorder. This project will also examine the effects of the device on depression, anxiety, and daytime sleepiness, and explore its effects on tic severity.

NCT ID: NCT05371041 Recruiting - Tourette Syndrome Clinical Trials

Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

The investigators will implant and monitor 8 research subjects with a subcortical closed-loop system for detection and suppression of tics. The project will use the FDA-approved "Medtronic Percept PC" device, which is an implantable neurostimulator capable of recording neural signals. The study will target the CM nucleus of the thalamus and the aGPi in each brain hemisphere from each subject and we will connect the two leads placed in each brain hemisphere to two Percept devices.

NCT ID: NCT05050734 Recruiting - Tourette Disorder Clinical Trials

Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)

Start date: September 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot trial is to examine the preliminary efficacy of online-delivered Comprehensive Behavioral Intervention for Tics - Enhanced (CBIT-E). In the study, 30 children with persistent tic disorders (PTDs) will be recruited via information provided to patients of the Marquette University (MU) Tic Disorders Specialty Clinic (TDSC) and information conveyed via local medical health professionals, with the goal of randomizing 10 participants to each group. For those randomized to CBIT-E, treatment will be administered according to the standard CBIT manual, but there will be two modifications. CBIT typically consists of the implementation of strategies to help manage the environment related to tics and the implementation of an exercise to engage in when an individual feels the urge to tic. CBIT-E will include these same techniques, plus additional in-session and out of session practice of the exercises, called competing responses, that individuals use when they feel the urge to tic. Treatment will be delivered over Microsoft Teams, which is a secure video conferencing system. The therapist will administer treatment from a private room in the Marquette University Tic Disorder Specialty Clinic, while the parent and child will be at their home. Treatment will include a screening visit, baseline assessment, 11 weeks (9 sessions) of CBIT-E, a post treatment assessment, and a three-month follow up assessment. Further, starting after session 3, there will be four 15-minute practice periods scheduled each week between sessions. During these practice periods, the child and therapist will meet over Microsoft Teams and the therapist will administer an enhanced reward task. Children randomized to the waitlist control (WLC) will not receive treatment during the 11-week period. Instead, they will be placed on a waitlist to receive standard CBIT following the end of the study period. Participants in this group will complete a screening visit, baseline assessment, and a final assessment, which will occur approximately 11 weeks after baseline.

NCT ID: NCT05047705 Recruiting - Tourette Syndrome Clinical Trials

Investigating Distress Tolerance in Adults With Tourette Syndrome

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

Although behavior therapy is recognized as a first-line intervention for Tourette's Disorder (TD), less than 40% of adults with TD respond to this evidence-based treatment. Limited tolerance for aversive premonitory urges and affective states that accompany tics may be one likely factor that impedes behavior therapy outcomes. This study examines the relationship between distress tolerance and tic inhibition among adults with TD, and investigates the mechanism and effect of therapeutic skills training to enhance distress tolerance abilities. Findings will determine the optimal approach to enhance distress tolerance among adults with TD and ultimately lead to better behavior therapy outcomes.